Skip to content

Clinical trials

Phase 3 Glioblastoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 3 Country / region: Canada Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20063
20071
20082
20094
20111
20141
20152
20161
20171
20181
20201
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Active, not recruiting3
Unknown status2
Withdrawn1
Suspended1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
Pfizer2
Radiation Therapy Oncology Group2
AHS Cancer Control Alberta1
AbbVie1
AstraZeneca1
Canadian Cancer Trials Group1
Celldex Therapeutics1
Colorado Health Foundation1
Denovo Biopharma LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma28
Brain Neoplasms10
Gliosarcoma10
Central Nervous System Neoplasms6
Neoplasms5
Glioma4
Astrocytoma3
Wilms Tumor1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.